Orasis Prepares To Battle AbbVie In Presbyopia
Qlosi Clears US FDA
The privately held firm got FDA approval for Qlosi, which like AbbVie’s Vuity is a low-dose formulation of pilocarpine for age-related near vision loss. Launch is planned for early 2024.
